Early Predictors of Mortality in Patients with COPD, in Relation to Respiratory and Non-Respiratory Causes of Death - A National Register Study.


Journal

International journal of chronic obstructive pulmonary disease
ISSN: 1178-2005
Titre abrégé: Int J Chron Obstruct Pulmon Dis
Pays: New Zealand
ID NLM: 101273481

Informations de publication

Date de publication:
2020
Historique:
received: 06 03 2020
accepted: 24 05 2020
entrez: 3 7 2020
pubmed: 3 7 2020
medline: 29 6 2021
Statut: epublish

Résumé

Both single factors and composite measures have been suggested to predict mortality in patients with chronic obstructive pulmonary disease (COPD) and there is a need to analyze the relative importance of each variable. To explore the predictors of mortality for patients with COPD in relation to respiratory, cardiac, and malignant causes, as well as all causes of death. After merging the Swedish Respiratory Tract Register (SRTR) and the Swedish Cause of Death Register, patients with respiratory, cardiac, and other causes of death were identified. Demographic and clinical variables from the deceased patients' first registration with the SRTR were compared. Three univariable and multivariable Cox proportional hazards regression analyses were conducted for different causes of death, with time from first registration to either death or a fixed end date as dependent variable, and variables regarding demographics, respiration, and comorbidities as independent variables. In the multivariable Cox models, mortality for patients with all causes of death was predicted by older age 1.79 (CI 1.41, 2.27), lower percentage of predicted forced expiratory volume in 1 second (FEV Obstruction predicted mortality in all models and dyspnea in two models and needs to be addressed. Comorbidity with heart disease could further worsen the COPD patient's prognosis and should be treated by a multidisciplinary team of professional specialists.

Sections du résumé

Background
Both single factors and composite measures have been suggested to predict mortality in patients with chronic obstructive pulmonary disease (COPD) and there is a need to analyze the relative importance of each variable.
Objective
To explore the predictors of mortality for patients with COPD in relation to respiratory, cardiac, and malignant causes, as well as all causes of death.
Methods
After merging the Swedish Respiratory Tract Register (SRTR) and the Swedish Cause of Death Register, patients with respiratory, cardiac, and other causes of death were identified. Demographic and clinical variables from the deceased patients' first registration with the SRTR were compared. Three univariable and multivariable Cox proportional hazards regression analyses were conducted for different causes of death, with time from first registration to either death or a fixed end date as dependent variable, and variables regarding demographics, respiration, and comorbidities as independent variables.
Results
In the multivariable Cox models, mortality for patients with all causes of death was predicted by older age 1.79 (CI 1.41, 2.27), lower percentage of predicted forced expiratory volume in 1 second (FEV
Conclusion
Obstruction predicted mortality in all models and dyspnea in two models and needs to be addressed. Comorbidity with heart disease could further worsen the COPD patient's prognosis and should be treated by a multidisciplinary team of professional specialists.

Identifiants

pubmed: 32612357
doi: 10.2147/COPD.S252709
pii: 252709
pmc: PMC7323789
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1495-1505

Informations de copyright

© 2020 Henoch et al.

Déclaration de conflit d'intérêts

The authors report no conflicts of interest in this work.

Références

Respir Med. 2010 Jun;104(6):773-9
pubmed: 20417082
Respir Med. 2008 Jun;102 Suppl 1:S27-35
pubmed: 18582794
Clin Respir J. 2016 Mar;10(2):142-52
pubmed: 25070878
Eur Respir J. 2008 Nov;32(5):1269-74
pubmed: 18579541
Age Ageing. 2012 Jul;41(4):545-9
pubmed: 22522776
Prim Care Respir J. 2012 Sep;21(3):295-301
pubmed: 22786813
Lancet Respir Med. 2017 Sep;5(9):691-706
pubmed: 28822787
Respiration. 2014;88(3):208-14
pubmed: 25115178
Eur Respir J. 2009 Sep;34(3):648-54
pubmed: 19720809
Respir Med. 2009 May;103(5):692-9
pubmed: 19131231
Thorax. 1999 Jul;54(7):581-6
pubmed: 10377201
COPD. 2013 Feb;10(1):79-103
pubmed: 23272663
J Thorac Dis. 2017 Mar;9(3):636-645
pubmed: 28449471
Eur Respir J. 2013 Aug;42(2):323-32
pubmed: 23222874
Int J Chron Obstruct Pulmon Dis. 2013;8:259-71
pubmed: 23754870
Thorax. 2014 Sep;69(9):799-804
pubmed: 24969641
Respir Med. 2018 Aug;141:14-19
pubmed: 30053959
Int J Chron Obstruct Pulmon Dis. 2011;6:521-6
pubmed: 22069363
Cochrane Database Syst Rev. 2015 Feb 23;(2):CD003793
pubmed: 25705944
J Thorac Dis. 2019 Apr;11(4):1379-1386
pubmed: 31179080
BMJ Open. 2012 Dec 12;2(6):
pubmed: 23242246
Chron Respir Dis. 2016 Aug;13(3):229-39
pubmed: 27072018
Drugs Aging. 2010 May;27(5):367-75
pubmed: 20450235
BMC Fam Pract. 2018 Nov 24;19(1):178
pubmed: 30474547
N Engl J Med. 2004 Mar 4;350(10):1005-12
pubmed: 14999112
Eur Respir J. 2006 Dec;28(6):1245-57
pubmed: 17138679
Int J Chron Obstruct Pulmon Dis. 2018 Oct 17;13:3389-3398
pubmed: 30410324
Respir Med. 2019 Aug;155:141-147
pubmed: 31362177
Chest. 2009 Mar;135(3):619-625
pubmed: 19029432
Multidiscip Respir Med. 2014 Sep 09;9(1):47
pubmed: 25485107
Chest. 2005 Dec;128(6):3810-6
pubmed: 16354849
J Gen Intern Med. 2008 Nov;23(11):1829-34
pubmed: 18795373
Respir Med. 2009 May;103(5):650-60
pubmed: 19167871
Chest. 2002 May;121(5):1441-8
pubmed: 12006426
Lancet. 2009 Aug 29;374(9691):704-11
pubmed: 19716962

Auteurs

Ingela Henoch (I)

Department of Research and Development, Angered Local Hospital, Gothenburg, Sweden.
Institute of Health and Care Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Ann Ekberg-Jansson (A)

Department of Research and Development, Region Halland, Halmstad, Sweden.
Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Claes-Göran Löfdahl (CG)

University of Lund, Lund, Sweden.
COPD Center, Institute of Medicine, Sahlgrenska University Hospital, University of Gothenburg, Gothenburg, Sweden.

Peter Strang (P)

Karolinska Institute, Department of Oncology-Pathology, Stockholm, Sweden.
Research and Development Unit, Stockholms Sjukhem Foundation, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH